Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000595460 | SCV001146725 | likely pathogenic | Phenylketonuria | 2019-04-09 | reviewed by expert panel | curation | The c.440C>T (p.Pro147Leu) variant in PAH has been reported in multiple individuals with mild PKU (BH4 deficiency excluded). (PP4_Moderate; PMID: 27121329, 26322415, 16527067, 30050108, 28982351). This variant is absent in population databases (PM2). This variant was detected in trans with known pathogenic variants p.R261Ter (PMID: 27121329); c.611A>G (PMID: 30050108); p.S70del (PMID: 28982351) (PM3_strong). Computational evidence supports a deleterious effect (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PM3_strong, PP3. |
Eurofins Ntd Llc |
RCV000088918 | SCV000709067 | pathogenic | not provided | 2017-06-16 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000595460 | SCV000799981 | likely pathogenic | Phenylketonuria | 2018-05-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000595460 | SCV004296182 | pathogenic | Phenylketonuria | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 147 of the PAH protein (p.Pro147Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with hyperphenylalaninemia (PMID: 26322415, 27121329, 31355225). ClinVar contains an entry for this variant (Variation ID: 102670). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Pro147 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10598814, 27121329). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
De |
RCV000088918 | SCV000119516 | not provided | not provided | no assertion provided | not provided |